IRadimed Corporation (IRMD)

NASDAQ: IRMD · IEX Real-Time Price · USD
32.01
-1.20 (-3.61%)
Jun 24, 2022 4:00 PM EDT - Market closed
-3.61%
Market Cap 402.07M
Revenue (ttm) 44.90M
Net Income (ttm) 10.43M
Shares Out 12.56M
EPS (ttm) 0.83
PE Ratio 38.61
Forward PE 32.15
Dividend $1.00 (3.12%)
Ex-Dividend Date Feb 16, 2022
Volume 84,390
Open 33.25
Previous Close 33.21
Day's Range 31.92 - 33.25
52-Week Range 27.72 - 55.92
Beta 0.99
Analysts Buy
Price Target 45.90 (+43.4%)
Earnings Date Jul 29, 2022

About IRMD

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensor... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Jul 16, 2014
CEO Roger Susi
Employees 110
Stock Exchange NASDAQ
Ticker Symbol IRMD
Full Company Profile

Financial Performance

In 2021, IRadimed's revenue was $41.81 million, an increase of 31.83% compared to the previous year's $31.72 million. Earnings were $9.33 million, an increase of 581.19%.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for IRMD stock is "Buy." The 12-month stock price forecast is 45.9, which is an increase of 43.39% from the latest price.

Price Target
$45.9
(43.39% upside)
Analyst Consensus: Buy
Stock Forecasts

News

IRADIMED Names John F. Glenn Chief Financial Officer

WINTER SPRINGS, Fla., May 26, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed Chief Financial Officer effective on or before June 2...

After Plunging 27.4% in 4 Weeks, Here's Why the Trend Might Reverse for iRadimed (IRMD)

iRadimed (IRMD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ea...

iRadimed (IRMD) is an Incredible Growth Stock: 3 Reasons Why

iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

IRadimed (IRMD) Q1 Earnings and Revenues Top Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 4.76% and 0.81%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

IRADIMED CORPORATION Announces First Quarter 2022 Financial Results

WINTER SPRINGS, Fla., April 29, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three months ended March 31, 2022. The Company...

IRADIMED CORPORATION Announces Executive Transition

WINTER SPRINGS, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today announced that Chris Scott, Chief Financial and Operating Officer, has resig...

IRADIMED CORPORATION to Hold 2022 First Quarter Financial Results Conference Call on April 29th

WINTER SPRINGS, Fla., April 05, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 first quarter financial results before the market open...

Here's Why Momentum in iRadimed (IRMD) Should Keep going

If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price St...

Is iRadimed (IRMD) Outperforming Other Medical Stocks This Year?

Here is how iRadimed (IRMD) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.

Recent Price Trend in iRadimed (IRMD) is Your Friend, Here's Why

iRadimed (IRMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

7 Safe Stocks to Rely On When the Market Swerves

When markets that have flown so high for so long start to tumble, along with an economy that transitioning, safe stocks are essential. The post 7 Safe Stocks to Rely On When the Market Swerves appeared ...

Other symbols: AMPHBLDRCHHCMCGAINNSSC

IRADIMED Announces Special $1.00 Per Share Cash Dividend

WINTER SPRINGS, Fla., Feb. 07, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors approved a special cash dividend of $1.00 per share on ...

Why iRadimed Shares Are Surging Today?

iRadimed Corporation IRMD reported Q4 FY21 sales of $11.87 million, up 39% Y/Y, beating the consensus of $11.63 million. Get the Inside Access Traders Are Using to Profit More and Win Bigger.

IRADIMED CORPORATION Announces Fourth Quarter 2021 Financial Results

WINTER SPRINGS, Fla., Feb. 04, 2022 (GLOBE NEWSWIRE) --  iRadimed Corporation (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices...

IRADIMED CORPORATION to Hold 2021 Fourth Quarter Financial Results Conference Call on February 4th

WINTER SPRINGS, Fla., Jan. 20, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 fourth quarter financial results before the market open...

iRadimed (IRMD) is on the Move, Here's Why the Trend Could be Sustainable

If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price St...

7 Excellent Small-Cap Stocks to Buy Before 2022

We've seen big tech rule the markets for a while, but now quality small-caps stocks are likely to begin stealing the headlines. The post 7 Excellent Small-Cap Stocks to Buy Before 2022 appeared first on...

Other symbols: ATENGAINIIINNMMPERIRYI

Here's Why "Trend" Investors Would Love Betting on iRadimed (IRMD)

If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price St...

3 Reasons Growth Investors Will Love iRadimed (IRMD)

iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

3 Reasons Why Growth Investors Shouldn't Overlook iRadimed (IRMD)

iRadimed (IRMD) could produce exceptional returns because of its solid growth attributes.

IRadimed (IRMD) Q3 Earnings and Revenues Beat Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 35.29% and 4.94%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

IRADIMED CORPORATION Announces Third Quarter 2021 Financial Results

WINTER SPRINGS, Fla., Oct. 29, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices ...

IRadimed (IRMD) Reports Next Week: Wall Street Expects Earnings Growth

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IRADIMED CORPORATION to Hold 2021 Third Quarter Financial Results Conference Call on October 29th

WINTER SPRINGS, Fla., Oct. 08, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 third quarter financial results before the market opens...

IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results

WINTER SPRINGS, Fla., July 30, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices ...